secwatch.observer — SEC 8-K summary
======================================

Issuer:     Mereo BioPharma Group plc (MREO)
CIK:        0001719714
Form:       8-K
Filed at:   2026-03-27T23:59:59+00:00
Accession:  0001193125-26-127253
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Dr. Annalisa Jenkins not seeking re-election to Mereo BioPharma board
---------------------------------------------------------------------

- Dr. Annalisa Jenkins will not stand for re-election at the 2026 AGM scheduled for May 14, 2026.
- Her decision did not result from any disagreement with the Company or Board on operations, policies, or practices.
- She will continue to serve as a director until her term expires immediately prior to the 2026 AGM.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1719714/000119312526127253/0001193125-26-127253-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1719714/000119312526127253/mreo-20260326.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-127253

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer